SCHEMBL4340966

SCHEMBL4340966

O=C1C=CC(=O)N1SS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL83079 0.73 MGLL (0.42)
SCHEMBL709406 0.73 MGLL (0.42)
SCHEMBL16256331 0.69
SCHEMBL24003668 0.69
SCHEMBL5577325 0.67 MGLL (0.43)
SCHEMBL29360862 0.66 MGLL (0.33)
SCHEMBL19954787 0.65 MGLL (0.35)
SCHEMBL23811171 0.64 XPO1 (0.32)
SCHEMBL19057261 0.63 MGLL (0.46)
SCHEMBL19413456 0.63 MGLL (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377473-B2 Albumin-binding prodrugs of auristatin E derivatives CENTURION BIOPHARMA CORPORATION (US) 2022-07-05 US disclosed
US-11129910-B2 Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof HANGZHOU DAC BIOTECH CO., LTD. (CN) 2021-09-28 US disclosed
US-20200385421-A1 ALBUMIN-BINDING PRODRUGS OF AURISTATIN E DERIVATIVES LADRX CORPORATION 2020-12-10 US disclosed
US-20200215206-A1 SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2020-07-09 US disclosed
US-10639381-B2 Trioxacarcins, trioxacarcin#antibody conjugates, and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2020-05-05 US disclosed
US-10414826-B2 Monomethylvaline compounds capable of conjugation to ligands SEATTLE GENETICS, INC. (US) 2019-09-17 US disclosed
US-20180221504-A1 TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-08-09 US disclosed
US-20180127512-A1 MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS SEAGEN INC. 2018-05-10 US disclosed
EP-2820013-A1 LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS Alexar Therapeutics, Inc. (US) 2015-01-07 EP disclosed
EP-2797875-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 Pharmacyclics, Inc. (US) 2014-11-05 EP disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 WO disclosed
EP-2582374-A2 METHODS FOR TREATING NEUROLOGICAL CONDITIONS Afraxis, Inc. (US) 2013-04-24 EP disclosed
WO-2013003629-A2 METHODS AND COMPOSITIONS FOR INHIBITION OF BONE RESORPTION PHARMACYCLICS, INC. (US) 2013-01-03 WO disclosed
WO-2011159945-A2 METHODS FOR TREATING NEUROLOGICAL CONDITIONS AFRAXIS, INC. (US) 2011-12-22 WO disclosed
CN-101861362-A Two chromophoric group carbonyls or heterocyclic dye, contain this dyestuff dye composite, adopt this dyestuff that keratin material is carried out painted method OREAL 2010-10-13 CN disclosed
CN-101684204-A Hemicyanin styryl thiol/disulfide dye, dye composition comprising this dye, process for lightening keratin materials using this dye OREAL 2010-03-31 CN disclosed
US-7598092-B2 Methods, devices, systems and computer program products for stochastic, competitive, force-based analyte detection TOONE ERIC 2009-10-06 US disclosed
WO-2008051314-A2 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STOCHASTIC, COMPETITIVE, FORCE-BASED ANALYTE DETECTION DUKE UNIVERSITY (US) 2008-05-02 WO disclosed
US-20080090259-A1 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STOCHASTIC, COMPETITIVE, FORCE-BASED ANALYTE DETECTION TOONE ERIC 2008-04-17 US disclosed
US-20070134762-A1 Immunogenic peptide carrier conjugates and methods of producing same WYETH LLC 2007-06-14 US disclosed